Simplex Trading’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4K Sell
5,000
-11,600
-70% -$45.7K ﹤0.01% 7030
2025
Q4
$67.6K Sell
16,600
-43,800
-73% -$196K ﹤0.01% 5381
2025
Q3
$214K Buy
60,400
+33,300
+123% +$120K ﹤0.01% 4868
2025
Q2
$73K Sell
27,100
-13,200
-33% -$27.2K ﹤0.01% 5541
2025
Q1
$67K Buy
40,300
+33,400
+484% +$93.4K ﹤0.01% 5491
2024
Q4
$11K Sell
6,900
-25,400
-79% -$75.7K ﹤0.01% 7145
2024
Q3
$134K Sell
32,300
-52,800
-62% -$277K ﹤0.01% 4933
2024
Q2
$464K Buy
85,100
+9,100
+12% +$72.5K ﹤0.01% 3749
2024
Q1
$760K Buy
+76,000
New +$569K ﹤0.01% 3414
2023
Q1
Sell
-1,200
Closed -$4K 9991
2022
Q4
$4K Sell
1,200
-6,000
-83% -$29.3K ﹤0.01% 8254
2022
Q3
$43K Buy
7,200
+5,100
+243% +$36.8K ﹤0.01% 6653
2022
Q2
$13K Hold
2,100
﹤0.01% 8067
2022
Q1
$17K Buy
2,100
+1,300
+163% +$10.5K ﹤0.01% 8420
2021
Q4
$12K Buy
800
+700
+700% +$13.5K ﹤0.01% 8880
2021
Q3
$1K Hold
100
﹤0.01% 9680
2021
Q2
$1K Buy
+100
New +$2.27K ﹤0.01% 9859

Other funds holding SANA

Simplex Trading's SANA Position: Q1 2026 in Review

Simplex Trading sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 5,996 shares — an estimated $23.6K sold.

Simplex Trading first reported a position in SANA in Q2 2021 and held it in 15 quarters. The position peaked at $465K in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Simplex Trading reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 5,996 Sana Biotechnology shares in Q1 2026, an estimated $23.6K.
  • Simplex Trading first reported a position in Sana Biotechnology in Q2 2021 and held it in 15 quarters.
  • Simplex Trading's Sana Biotechnology position peaked at $465K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.